Ordering Single Cells and Single Embryos in 3D Confinement: A New Device for High Content Screening
September 18th, 2016
8.1K views
We report a device and a new method to study cells and embryos. Single cells are precisely ordered in microcavity arrays. Their 3D confinement is a step towards 3D environments encountered in physiological conditions and allows organelle orientation. By controlling cell shape, this setup minimizes variability reported in standard assays.
Overview
This study presents a novel device and method for examining cellular morphology and dynamics in a 3D environment. By utilizing microcavity arrays, single cells can be precisely ordered, allowing for better organelle orientation and reduced variability compared to standard assays.
Key Study Components
Area of Science
- Cell biology
- Neuroscience
- 3D cell culture
Background
- Understanding cellular dynamics is crucial for biological research.
- Standard 2D assays often fail to replicate physiological conditions.
- 3D environments can enhance the study of organelle behavior.
- Microcavity arrays provide a controlled setting for cell studies.
Purpose of Study
- To observe the morphology and dynamics of cellular organelles.
- To create a 3D environment that mimics physiological conditions.
- To compare cell behavior in 3D versus traditional 2D assays.
Methods Used
- Fabrication of PDMS microcavity arrays through replica molding.
- Functionalization of microcavities with extracellular matrix proteins.
- Introduction of individual mammalian cells into microcavities.
- Incubation with drugs to study cellular responses.
Main Results
- Differences in cell phenotype were observed in 3D confinement.
- Novel dynamic structures were identified compared to 2D assays.
- The method minimized variability in cell orientation.
- Enhanced understanding of organelle dynamics was achieved.
Conclusions
- The microcavity array method provides a significant advancement in cell studies.
- 3D environments are essential for accurate biological assessments.
- This approach could lead to improved drug testing and cellular analysis.
Frequently Asked Questions
What is the significance of using microcavity arrays?
Microcavity arrays allow for precise organization and orientation of cells, mimicking physiological conditions more closely than traditional 2D cultures.
How does this method compare to standard assays?
This method reduces variability and enhances the observation of cellular dynamics and organelle behavior, providing more reliable results.
What types of cells can be studied using this technique?
The technique is suitable for various cell types, including mammalian cells and organisms with rigid cell walls, like fission yeast.
What are the potential applications of this research?
Applications include drug testing, understanding disease mechanisms, and improving tissue engineering approaches.
How does the functionalization of microcavities enhance the study?
Functionalization with extracellular matrix proteins promotes cell adhesion and mimics the natural environment, improving experimental relevance.
Executive Industry Relevance
Standard 2D cell culture assays limit phenotypic reproducibility and obscure organelle dynamics due to non-physiological growth conditions. This microcavity array device enables ordered single-cell confinement in a 3D extracellular matrix-mimicking environment, reducing morphological heterogeneity and enhancing detection of subcellular structures and dynamic processes. The improved phenotypic consistency supports more reliable high-content screening and mechanistic de-risking in early drug discovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by normalizing cell position, shape, polarity, and internal organization in a physiologically relevant 3D context.
- Operational Value: Reduces biological noise from heterogeneous cell morphologies, improving confidence in target engagement and pathway modulation readouts.
Screening & Assay Development
- Scientific Value: Facilitates visualization of organelles such as nucleus and Golgi apparatus and detection of novel dynamic structures like periodic myosin accumulations during cytokinetic ring closure.
- Operational Value: Standardizes cell preparation via centrifugation-based filling, achieving up to 80% occupancy with reproducible viability across mammalian cells, yeast, and embryos.
Translational & Preclinical Research
- Scientific Value: Reveals drug-induced phenotypes masked in 2D, such as Blebbistatin effects on stress fiber reduction and nuclear orientation, enabling mechanistic de-risking.
- Operational Value: Supports adaptation to diverse model systems including fission yeast, budding yeast, and C. elegans, broadening preclinical relevance.
Pipeline & Workflow Integration
The device bridges early discovery and lead identification by providing standardized 3D-confined cellular systems that improve assay readiness and data consistency before compound screening.
- Discovery Biology: Supports hypothesis testing through ordered arrays that clarify subcellular dynamics and reduce variability in organelle orientation.
- Screening: Enables assay standardization via uniform microcavity dimensions (105 cavities/cm2) and extracellular matrix functionalization with fibronectin.
- Analytics: Generates quantitative morphological and dynamic readouts (e.g., nucleus sphericity, Golgi compaction, actin/myosin ring dynamics) for comparative condition analysis.
- Translational Research: Maintains continuity from discovery to preclinical by preserving viability and enabling longitudinal observation of active processes like cytokinetic ring closure.
- Enterprise Reuse: Fabricated via replica molding, allowing rapid preparation (<6 hours) and reuse across multiple cell types and screening campaigns.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through reduced phenotypic variability and enhanced detection of novel subcellular dynamics.
- Operational Value: Standardization, reproducibility, and scalability via PDMS microcavity arrays and optimized cell loading protocols.
- Strategic Value: Improved go/no-go decisions by unmasking drug effects obscured in 2D cultures, reducing late-stage biological risk.
- Portfolio Impact: Risk-adjusted prioritization via reliable organelle-level phenotyping in disease-relevant 3D contexts.
Implementation Considerations
- Requires expertise in microfabrication, PDMS handling, and oxygen plasma activation for replica molding.
- Depends on access to centrifuge, plasma cleaner, fluorescence microscopy, and fibronectin for extracellular matrix functionalization.
- Necessitates cross-team standardization of cell preparation, filling optimization, and incubation timing across biology and assay development groups.
- Involves adaptation considerations for varying cell sizes and wall properties (e.g., mammalian vs. yeast vs. embryo) to maintain loading efficiency.
- Practical limitations include the need for careful handling to avoid PDMS detachment and the requirement to match cavity dimensions to target cell size for optimal ordering.
Biopharma FAQs
Why does normalizing cell position and shape matter for target validation?
Normalizing cell position, shape, polarity, and internal organization in 3D microcavities reduces morphological heterogeneity, which improves the reliability of target engagement and pathway modulation readouts in early discovery.
How does isolating the variable of 3D confinement fit the discovery pipeline?
Isolating 3D confinement as a controlled variable enables comparison of cellular phenotypes between standard 2D and physiologically relevant environments, clarifying context-dependent drug responses.
What quantitative measurements of organelle dynamics enable screening readiness?
Quantitative metrics such as nucleus sphericity, Golgi apparatus compaction, and periodic myosin-actin accumulations during cytokinetic ring closure provide measurable, comparable readouts for compound screening.
Why do replication requirements matter for cross-functional collaboration?
Reproducible filling percentages (up to 80%) and consistent viability across cell types ensure that assay results are reliable and transferable between biology, screening, and analytics teams.
What statistical analysis capabilities are required before implementing this assay?
The ability to compare condition-dependent changes in organelle orientation and dynamic processes (e.g., stress fiber reduction, ring closure kinetics) is essential to detect drug effects masked in 2D cultures.
Chapters in this video
0:05
Title
2:29
Microfabrication of 'Eggcups'
6:29
Introducing Cells into the 'Eggcups'
9:31
Observation of Fixed Cellular Organelles in 'Eggcups'
11:22
Results: 'Eggcups' Enable Visualization of Cellular Organelles and Study of Dynamic Cell Processes
13:27
Conclusion
